Recently, at the "2013 China (Tangyin) Bianxi Biomedical Development Forum" jointly sponsored by China Medical Science and Technology Achievement Transformation Center, China Pharmaceutical Enterprise Development Promotion Association and Henan Tangyin County People's Government, experts and scholars around China's medical care The development trend of the device has been discussed in depth. Experts stressed that the medical device industry has become an important starting point for the developed countries to upgrade the biomedical industry and high-end equipment manufacturing. At present, China's medical device industry has a large distance compared with developed countries. Domestic enterprises must review the situation and seize opportunities, and strive to seek development in the game of opportunities and challenges.
Looking for "short board"
China Medical Device Industry Association Yan Shanshan said that in 2012, the global medical device market exceeded US$400 billion, accounting for 42% of the global pharmaceutical market. Developed countries attach great importance to the medical device industry, and their ratio of drug and machine output reached 1:1. China's medical device industry has also established a certain foundation. It is estimated that in 2012, the industry achieved a total production value of about 300 billion yuan, and industrial sales revenue of about 300 billion yuan. According to the website of the State Food and Drug Administration, as of the end of 2012, there were 15,348 medical device manufacturers and 172,378 operating enterprises in China; there were 69,975 medical device product registration certificates in China, including 21,882 first-class medical device registration certificates. There are 27,326 medical device registration certificates, 5,242 medical device registration certificates, and 15,525 imported medical device registration certificates. According to customs statistics, in 2012, China’s total import and export of medical equipment was US$30.62 billion, of which exports amounted to US$17.59 billion and imports amounted to US$12.472 billion.
“The rapid development of the industry, the large scale of the market, the rapid development of international trade, the strong support of disciplines, and the increasing emphasis on R&D are the main advantages of the industry, but the disadvantages are also obvious.†Deputy Director, Frontier Biotechnology Division, China Biotechnology Development Center Dr. Yu Zhenxing pointed out that China's medical device manufacturers are generally small in scale. The average output value of domestic pharmaceutical companies is about 140 million yuan, while the average output value of medical device enterprises is less than 20 million yuan. China can produce more than 3,500 kinds of medical devices, and each product has more than ten registration certificates on average, which means that the homogenization competition is serious.
"China's medical device research institutions, high-end talents and compound talents are all lacking. Therefore, the overall technical level of domestic medical devices is not high, new product development is lagging behind, and product updates are slow. At present, the main share of China's middle and high-end medical device market is transnational. In 2010, the number of first-class registrations of imported three types of equipment reached 1963, while the number of first-time registrations of domestically-made three types of equipment was 562, less than 1/3 of the former.†Dr. Yu Zhenxing continued to analyze that there are only more than 100 in China. The college has established biomedical engineering related majors, and there are more than 700 colleges and universities offering pharmacy related majors. There are few national key laboratories and national engineering technology centers related to medical devices. The government's funds for supporting medical device research and development during the 11th Five-Year Plan and the 12th Five-Year Plan period are less than 10% of the investment in new drug research and development, and the company's R&D investment is less. In contrast, Johnson & Johnson, Abbott, and Siemens Healthcare, which rank among the top 10 companies in the world in medical device R&D, have a global R&D budget of $7.5 billion, $4.1 billion, and $1.56 billion respectively.
Female Health Plant Extract,Saw Palmetto Extract,Saw Palmetto Extract Powder,Saw Palmetto Fruit Extract
Youth Biotech CO,. Ltd. , https://www.youtherb.com